Editorial: Farewell to 2009!

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 8, 2009, Pages 715-718

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEMOSTASIS; MEDICAL RESEARCH; PRIORITY JOURNAL; THROMBOSIS; BLOOD; HEMATOLOGY; HUMAN; JOURNAL IMPACT FACTOR; PUBLICATION;

HEMATOLOGY; HEMOSTASIS; HUMANS; JOURNAL IMPACT FACTOR; PERIODICALS AS TOPIC; THROMBOSIS;

EID: 77449141468     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1245103     Document Type: Editorial

References (40)

1. Schiff D, Burgess T. Editorial. Semin Thromb Hemost 2004 30 601-602
2. Favaloro E J. Editorial. Welcome to Seminars in Thrombosis and Hemostasis2008! Semin Thromb Hemost 2008 34 1-2
3. Schiff D. Eulogy. Eberhard Mammen, M.D. 19302008. Semin Thromb Hemost 2008 34 305-306
4. Favaloro E J. Editorial. Semin Thromb Hemost 2008 34 307-308
5. Favaloro E J. Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasisthe closing issue for 2008. Semin Thromb Hemost 2008 34 693-696
6. Prasad A, Kwaan H C. In memoriam: a tribute to Eberhard F Mammen, M.D. (19302008). Semin Thromb Hemost 2008 34 697-698
7. Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (19302008). Semin Thromb Hemost 2008 34 (8) 703-707
8. Favaloro E J. Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009 35 1-2
9. Favaloro E J. Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story. Semin Thromb Hemost 2008 34 (1) 7-25
10. Favaloro E J. The Journal Impact Factor: don't expect its demise any time soon. Clin Chem Lab Med 2009 47 (11) 1319-1324
11. Esmon C T. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006 32 (suppl 1) 49-60
12. sterud B, Bjrklid E. Sources of tissue factor. Semin Thromb Hemost 2006 32 (1) 11-23
13. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 2006 32 (1) 54-70
14. Versteeg H H., Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 2006 32 (1) 24-32
15. Ruf W, Mueller B M. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 2006 32 (suppl 1) 61-68
16. Favaloro E J. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Semin Thromb Hemost 2006 32 (5) 456-471
17. Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006 32 (1) 33-39
18. Davie E W., Kulman J D. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006 32 (suppl 1) 3-15
19. Tefferi A, Elliott M. Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost 2007 33 (4) 313-320
20. Michiels J J., De Raeve H, Berneman Z et al. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Semin Thromb Hemost 2006 32 (4 Pt 2) 307-340
21. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin Thromb Hemost 2006 32 (suppl 1) 77-85
22. Roberts H R., Hoffman M, Monroe D M. A cell-based model of thrombin generation. Semin Thromb Hemost 2006 32 (suppl 1) 32-38
23. Kucher N, Goldhaber S Z. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost 2006 32 (8) 838-847
24. Michiels J J., Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Semin Thromb Hemost 2006 32 (3) 174-207
25. Lawson J H. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost 2006 32 (suppl 1) 98-110
26. de Lamirande E. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost 2007 33 (1) 60-68
27. Favaloro E J. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Semin Thromb Hemost 2006 32 (5) 537-545
28. Kavanagh D, Goodship T H. Membrane cofactor protein and factor I: mutations and transplantation. Semin Thromb Hemost 2006 32 (2) 155-159
29. Siegel-Axel D I., Gawaz M. Platelets and endothelial cells. Semin Thromb Hemost 2007 33 (2) 128-135
30. Qu L, Kiss J E. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost 2005 31 (6) 691-699
31. Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost 2006 32 (1) 5-10
32. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005 31 (6) 681-690
33. Ferro V, Dredge K, Liu L et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin Thromb Hemost 2007 33 (5) 557-568
34. Favaloro E J., Bonar R, Kershaw G et al. Reducing errors in identification of von Willebrand disease: the experience of the Royal College of Pathologists of Australasia quality assurance program. Semin Thromb Hemost 2006 32 (5) 505-513
35. Rock G. The management of thrombotic thrombocytopenic purpura in 2005. Semin Thromb Hemost 2005 31 (6) 709-716
36. Griesshammer M. Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia. Semin Thromb Hemost 2006 32 (4 Pt 2) 372-380
37. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost 2006 32 (8) 803-809
38. Budde U, Metzner H J., Mller H G. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. Semin Thromb Hemost 2006 32 (6) 626-635
39. Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006 32 (7) 651-658
40. Hayward C P., Eikelboom J. Platelet function testing: quality assurance. Semin Thromb Hemost 2007 33 (3) 273-282